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CaV1.2 Calcium Channel Dysfunction
Causes a Multisystem Disorder
Including Arrhythmia and Autism
ultimate signaling molecule for organisms ranging from
prokaryotes to humans. In higher organisms, Ca2 medi-
ates processes as diverse as synaptic transmission,
muscle contraction, insulin secretion, fertilization, and
gene expression (Berridge et al., 2003; Brini and Carafoli,
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Silvia G. Priori,4,5 Michael C. Sanguinetti,3 2000; Ren et al., 2001). Because Ca2 cannot be metabo-
lized, cells have evolved complex mechanisms for regu-and Mark T. Keating1
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et al., 1993). By contrast with physiology, the role ofUniversity of Utah
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4 Department of Molecular Cardiology The importance and ubiquity of Ca2 as an intracellular
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University of Pavia Previously characterized calcium channel disorders,
6 IRCCS Policlinico San Matteo however, have been marked by dysfunction of a distinct
27100 Pavia organ system, particularly the membrane excitability of
Italy neurons and skeletal muscle. For example, calcium
7 Department of Anatomy and Neurobiology channel syndromes like hypokalemic periodic paralysis
Boston University School of Medicine and malignant hyperthermia affect skeletal muscle
Boston, Massachusetts 02118 (Monnier et al., 1997; Ptacek et al., 1994), episodic ataxia
affects the cerebellum (Ophoff et al., 1996), familial hemi-
plegic migraine affects vascular smooth muscle (Ophoff
Summary et al., 1996), and stationary night blindness affects retina
(Bech-Hansen et al., 1998; Strom et al., 1998). None of
CaV1.2, the cardiac L-type calcium channel, is impor- these disorders has illustrated the full extent of Ca2
tant for excitation and contraction of the heart. Its role signaling in human development and physiology.
in other tissues is unclear. Here we present Timothy Cardiac arrhythmias cause sudden loss of conscious-
syndrome, a novel disorder characterized by multior- ness and sudden death in approximately 1 million Euro-
gan dysfunction including lethal arrhythmias, webbing peans and North Americans every year (Priori et al.,
of fingers and toes, congenital heart disease, immune 2002; Zheng et al., 2001). Over the last decade, we and
deficiency, intermittent hypoglycemia, cognitive ab- others have identified arrhythmia susceptibility genes
normalities, and autism. In every case, Timothy syn- by studying familial syndromes (Antzelevitch, 2003;
drome results from the identical, de novo CaV1.2 mis- Keating and Sanguinetti, 2001). These genes include
sense mutation G406R. CaV1.2 is expressed in all SCN5A, KVLQT1, and HERG, which encode important
affected tissues. Functional expression reveals that cardiac sodium and potassium channels. In the vast
G406R produces maintained inward Ca2 currents by majority of arrhythmia syndromes, individuals appear
causing nearly complete loss of voltage-dependent normal except for subtle electrocardiographic abnor-
channel inactivation. This likely induces intracellular malities.
Ca2 overload in multiple cell types. In the heart, pro- Here, we describe the phenotypic characterization of
longed Ca2 current delays cardiomyocyte repolariza- Timothy syndrome (TS), an arrhythmia disorder associ-
tion and increases risk of arrhythmia, the ultimate ated with dysfunction in multiple organ systems, includ-
cause of death in this disorder. These discoveries es- ing congenital heart disease, syndactyly, immune defi-
tablish the importance of CaV1.2 in human physiology ciency, and autism. We show that this disorder results
and development and implicate Ca2 signaling in from a recurrent, de novo missense mutation in the
autism. CaV1.2 L-type calcium channel gene. The CaV1.2 gene is
expressed in multiple tissues. We demonstrate through
Introduction functional expression in heterologous systems that the
disease-associated mutation causes abnormal Ca2
“Ja, Kalzium, das ist alles!” So stated Nobel laureate current. This gain-of-function mechanism is mediated
Otto Loewi in 1959, and it is now clear that Ca2 is the through failed channel inactivation, suggesting that cal-
cium channel blockers may be useful for treating this
and related disorders.*Correspondence: igor@enders.tch.harvard.edu
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Results syndrome. By contrast, the complexity of the TS pheno-
type suggested a second possibility, a contiguous gene
deletion syndrome or a chromosomal rearrangement.Timothy Syndrome, a Multisystem Disorder
Karyotypic analysis of metaphase chromosomes fromIn 1992, cases of a novel arrhythmia syndrome associ-
11 children failed to reveal defects (data not shown). Thisated with syndactyly (webbing of fingers and toes) were
analysis, however, would not exclude small deletions.described (Marks et al., 1995; Reichenbach et al., 1992).
A consistent feature of TS was severe QT intervalWe named this disorder Timothy syndrome (TS). Be-
prolongation. Therefore, to define the genetic basis ofcause therapy is extending lives of affected children,
this disorder, we screened known long QT syndromewe have observed that TS manifests major phenotypic
genes, including HERG, KVLQT1, KCNE1, KCNE2, SCN5A,abnormalities of multiple organ systems, including
and KCNJ2, by single-strand conformation polymor-heart, skin, eyes, teeth, immune system, and brain (Fig-
phism (SSCP) and/or DNA sequence analyses. We alsoure 1, Table 1).
examined several other genes encoding channel orThe inheritance pattern of TS was sporadic in all but
channel-associated subunits, including FKBP1A, KCNA4,one family. In that family, two of three siblings were
KCNA5, KCND3, KCNE3, KCNIP2, KCNJ4, KCNJ9,affected. None of the parents in any of the families was
KCNJ10, KCNJ12, NCX1, SCN1B, DNAJB1, and TRPC3.affected. Ten of 17 children with TS died. The average
The transcription factors TFAP2B, FOG2, NKX2.5, andage of death was 2.5 years. All affected individuals had
GATA4 were tested because they have been implicatedsevere prolongation of the QT interval on electrocardio-
in one or more phenotypic features of TS. No mutationsgram, syndactyly, and abnormal teeth and were bald at
were identified.birth. Arrhythmias were the most serious aspect of this
The abnormal electrocardiographic morphology ob-disorder, as 12 of 17 children had life-threatening epi-
served in TS patients was similar to that of individualssodes. Arrhythmic death in two children was triggered
with long QT syndrome caused by gain-of-function mu-by sepsis and in two other children by episodic hypogly-
tations in SCN5A, the cardiac sodium channel (Zhangcemia. Individuals with this syndrome also had congeni-
et al., 2000). The cardiac L-type calcium channel CaV1.2,tal heart disease including patent ductus arteriosus, pa-
like SCN5A, mediates an inward depolarizing current intent foramen ovale, ventricular septal defects, and
cardiomyocytes. Thus, in 1996, we examined the CaV1.2tetralogy of Fallot. Some children had dysmorphic facial
gene as a candidate. SSCP analyses of 47 exons andfeatures, including a flat nasal bridge, small upper jaw,
promoter regions did not show mutations (Table 2).low-set ears, or small and misplaced teeth. Episodic
However, new alternatively spliced forms of the CaV1.2serum hypocalcemia was described in four individuals.
gene were subsequently identified (Abernethy and Sol-Many of the surviving children showed developmental
datov, 2002). Analysis of one CaV1.2 splice variant re-delays consistent with language, motor, and generalized
vealed a G1216A transition in exon 8A in all 13 individualscognitive impairment. Children had a history of language
for whom DNA samples were available (Figures 2A anddelay and delay in other motor skills. Many did not pro-
2B). This transition caused a substitution of glycine withduce speech sounds (babbling) during infancy. Testing
arginine at residue 406 (G406R). This amino acid is com-revealed significant problems in language skills includ-
pletely conserved in other voltage-dependent calciuming articulation, reception, and expression. Children
channels of multiple species, ranging from worms towere impaired in all areas of adaptive function, including
humans (Figure 2C). G406 is located at the C-terminalcommunication, socialization, and daily living skills. Five
end of the sixth transmembrane segment of domain I (DI/children were formally evaluated for autism. Three met
S6, Figure 2D). The G406R mutation was not identified inthe criteria for this disorder, one met criteria for autism
180 ethnically matched control samples (360 chromo-spectrum disorders, and one had severe delays in lan-
somes, p  1.8  1020).guage development. We could not evaluate additional
Mutational analysis of additional family members, in-
children because they were deceased or unavailable.
cluding parents, failed to reveal mutations at this site.
However, the association between autism spectrum dis-
Thus, the phenotype in all probands resulted from the
orders and Timothy syndrome was significant (p 1.2 same de novo mutation. However, in one family, two
108). Taken together, the diversity of these phenotypic siblings had the syndrome (Figure 2B). Both parents
abnormalities indicates a complex physiological and de- were phenotypically unaffected. The probability of the
velopmental disorder. mutation event happening twice in the same family was
minimal. To explain this apparent paradox, we hypothe-
Recurrent De Novo Missense Mutation sized that one parent was mosaic for the mutation. Mo-
in CaV1.2 Causes TS saicism is defined by the presence of two or more geneti-
The TS phenotype suggested two possible genotypes. cally different cell types in the same organism. To test
The severity of arrhythmias in this disorder suggested this hypothesis, we sequenced DNA samples from the
a recessive gene knockout similar to Jervell and Lange- father’s sperm and blood, but the mutation was not
Nielsen syndrome, which is caused by homozygous observed. In the mother, we sequenced DNA samples
loss-of-function mutations of KVLQT1 or KCNE1 potas- from blood and oral mucosa. Although the blood DNA
sium channel genes (Neyroud et al., 1997; Schulze-Bahr contained only wild-type sequences, we were able to
et al., 1997; Splawski et al., 1997a; Tyson et al., 1997). detect a small peak for the missense mutation in DNA
Consistent with this thesis, all parents were unaffected, from the oral mucosa (Figure 2B). These findings indi-
and one of the families had two children with TS. How- cate that the mother is mosaic and transmitted this mu-
ever, none of the parents from any family were related, tation to her two affected children. To further test this
hypothesis, we performed genotypic analysis in thisand consanguinity would be expected in a rare recessive
Calcium Channel Mutation in Arrhythmia and Autism
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Figure 1. Timothy Syndrome Is Characterized by Multisystem Dysfunction and Developmental Defects
(A–C) TS individuals exhibiting dysmorphic facial features including round face, flat nasal bridge, receding upper jaw, and thin upper lip.
(D and E) Webbing of the toes and fingers (syndactyly).
(F) Left panel electrocardiogram shows severe QT interval prolongation causing 2:1 atrioventricular block seen as two atrial beats (P-waves)
for each ventricular beat (QRS complex). Right panel electrocardiogram shows alternating T-wave polarity (arrows), indicating severe cardiac
repolarization abnormality.
(G) Ventricular tachycardia recorded from a TS patient by an implanted automatic defibrillator.
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Exons 8 and 8A are mutually exclusive as they encodeTable 1. Phenotypic Features of Timothy Syndrome
the same structural domain (DI/S6), but one must be
Phenotype Affecteda (%)
present to encode a functional channel. To quantify the
Heart relative expression of exons 8 and 8A in human heart
QT prolongation 100 and brain, we cloned these exons from cDNAs. We found
Arrhythmia
that 23 of 101 clones (22.8%) from heart cDNAs con-(1) Ventricular tachyarrhythmia 71
tained exon 8A, and 78 clones (77.2%) contained exon(2) Bradycardia, AV blockb 94
8. In the brain, 13 of 56 clones (23.2%) contained exonPatent ductus arteriosus 59
Patent foramen ovale 29 8A, and 43 clones (76.8%) contained exon 8. The relative
Ventricular septal defects 18 expression of exon 8A is consistent in heart and brain
Tetralogy of Fallot 6 and is expressed at significantly lower levels than
Cardiomegaly 35
exon 8.CNS
To define the cellular distribution of CaV1.2 gene ex-Autism 60
pression, we performed in situ hybridization experi-Autism spectrum disorders 80
Mental retardation 25 ments in mice. CaV1.2 was expressed throughout the
Seizures 21 brain (Figure 4A), including hippocampus, cerebellum,
Umbilical cord and amygdala. Abnormalities of these brain regions
Two vessel 13
have been implicated in autism (Allen and Courchesne,Gastrointestinal
2003; Brambilla et al., 2003). CaV1.2 showed highestGag reflex 31
expression in the granular layers of hippocampal den-Skin
Syndactyly 100 tate gyrus (Figures 4A and 4B) and cerebellum (data not
Bald at birth 100 shown). CaV1.2 was also expressed throughout the heart
Face (Figures 4C and 4D) and the vascular system, including
Dysmorphia 53
ductus arteriosus (Figure 4E). In the eye, CaV1.2 wasEyes
expressed in the retina and sclera (Figure 4F). CaV1.2Myopia 25
was also expressed in developing digits and teeth (Fig-Nose
Sinusitis 29 ures 4G and 4H). Thus, the expression pattern of CaV1.2
Teeth in humans and mice is consistent with the phenotypic
Small 100 abnormalities associated with TS.
Cavities 50
Lungs
G406R Mutation Impairs Channel InactivationPneumonia/bronchitis 47
Pulmonary hypertension 21 To determine the molecular consequences of the G406R
Hypothyroidism 8 mutation, we heterologously expressed wild-type (wt)
Hypocalcemia 33 and mutant (G406R) forms of the CaV1.2 channel in Chi-Hypoglycemia 36
nese hamster ovary (CHO) cells and Xenopus oocytes.Hypothermia 33
The biophysical properties of the channel were firstMuscoskeletal
characterized by standard whole-cell patch-clamp tech-Hypotonia 40
Immunodeficiency/recurrent infections 43 niques using Ca2 (15 mM) as a charge carrier in CHO
cells cotransfected with CaV1.2 and its accessory sub-a Nine affected individuals were male, and eight were female.
units, CaV2b and CaV21. The most striking differenceb Atrioventricular block.
between wt and G406R channels was the extent of inac-
tivation. Inactivation of wt channel current was nearly
complete in 300 ms (Figure 5A). In contrast, G406R chan-family. We found that the G406R mutation resided on
the maternal chromosome. Thus, in one case, G406R nels only partially inactivated during the same time pe-
riod (Figure 5B). Next, we assessed the voltage depen-arose de novo in a parent during development, leading
to mosaicism. Taken together, these data indicate that dence of Ca2 current inactivation. Wild-type channel
inactivation was complete at 20 mV and slightly de-a recurrent, de novo G406R mutation of the CaV1.2 gene
causes TS. creased at more positive potentials, as expected for
partial relief of the Ca2-dependent component of inacti-
vation (Lee et al., 1985) (Figure 5C). In contrast, theCav1.2 Is Widely Expressed
Previous studies indicate that the CaV1.2 gene was ex- maximum attained inactivation was only 56% for G406R
channels. Relief of inactivation was greater for G406Rpressed in heart, brain, smooth muscle, and pituitary
and adrenal glands (Ertel et al., 2000). However, the TS compared to wt channels at potentials30 mV (Figure
5C). This observation suggests that mutant channelsphenotype suggested a broader expression pattern of
the alternatively spliced form of CaV1.2 containing exon have lost voltage-dependent Ca2current inactivation.
The time constant for inactivation (	) was a U-shaped8A. To determine the pattern of expression in humans,
we used exon 8A as a probe for Northern and dot blot function of voltage for wt channels but increased with
membrane voltage for mutant channels (Figure 5D). Theanalyses (Figure 3). This exon was highly expressed in
adult heart, and the mRNA was9 kb (Figure 3A). mRNA current amplitudes measured at the peak of the current-
voltage (I/V) relationship were similar (p  0.32) andcontaining exon 8A was also expressed in multiple adult
and fetal tissues, including brain, gastrointestinal sys- averaged 70 
 12 pA for wt (n  11) and 94 
 20 pA
for G406R (n  9). The shape of the normalized I/Vtem, lungs, immune system, smooth muscle, and testis.
These data indicate that exon 8A of the CaV1.2 gene is relationship (Figure 5E) was only slightly altered by the
mutant channels, consistent with a mere 3 mV shift inwidely expressed in humans.
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Table 2. Oligonucleotide Pairs Used to Amplify Exons of CaV1.2 Gene
Exon Forward Oligonucelotide Reverse Oligonucleotide Size (C)a
1 TGAGCAGGATAATTATTTAGCTTT TTCAACATGTTCTTCCTACTCTT 246 (1)
1A ACATTTCTTCCTCTTCGTGGC GCGGGTAGGGCAGGAACC 167 (2)
2b TGCCCCTGTTTTCTATCTAGTA CGCTGCGTGGAGCTGACTG 245 (2)
2b ATGGGCAGCGCTGGCAATG GCATGCCCAGCCCGGTGAA 208 (2)
3 GTACTTTCTGTGGCATTAACTTC CGCAGTTCTCCATCGAGTGA 198 (1)
4 AATCCCCAAACCAATGACTTATT GTCCCGCAACACTGGTAAGAT 243 (1)
5 GGGCAAAAGAAAACCCAGTCC CTGTACACAAGAACGGGCTTC 219 (1)
6 TACCGCGGTGATGCTTGGTT GGGCCTTGGGAGCGCAGC 237 (2)
7 CCCTGCTGCTCCCGTCTC TGACTGCCCACTCATGCTAC 262 (2)
8 CTTCTTTCCTAACTTTCCTTCG CTGCGTTGTGGAGAGGACATA 172 (1)
8A GTGCCTCACTAACTATCATTCC AAATCAAGACCTTTTTCCTTGGT 168 (2)
9 CCTGCCCCTCCTCTCACTC CCCAAACACAGAAGAAGACGG 228 (2)
10 TCCCCACCCTCAATGCCTG GAAAAAGCCCCAGCCCCTG 175 (2)
11 ATCAAATTTCCCTGGGACTGTT AGGAAGGAAGAGCAGCGTGA 142 (1)
12 CAGCCAACCCCACCCTTCT TACCAGGAGGAAACCAGAGCA 240 (2)
13 CTGGCCCTGCTCGGATCTC AAGAACTTCTTCCTGAGTCCC 318 (1)
14 GGGCAGAGTGCTGACCTCC ACCCCGAGTCCGAATCCCA 285 (1)
15 AACGCTGTGTCCCTTATTGGT GGGGCAGCAGCAAAGGATAC 179 (1)
16 AACCAAGGGTCATTTTCTTTAAG CAGGCCTGGGCAAGCTTAGA 180 (1)
17 TCACTCCAGTAAACAGCCATT ACAGCTCCAGGAAGGAGACA 198 (1)
18 CCCCTTCTCCCCTGTGACT CTCCCAATCCCAGGTTAGGC 129 (1)
19 AGTGGGAGTGCTGGAGTTATT TGCCAGGCTGGTACTAGAGAG 235 (2)
20 TCTCTCCTCCTGTCCCCTCT TGCAGAAGACACAGGCGATG 184 (2)
21 CATCCCATCCCCACCCTGTT TGCTGGCACAAGGGGGACA 144 (2)
22 ACTCTCAGAGCCACTAATCCAA GAGATAGACAAAGAAAGCGACA 148 (1)
23 GGCCACTCACACTGGTGTTC AGCTGCATGGCCCATCGTG 185 (1)
24 CCAGAAACAGGAGGAGCTTAC CTGGAGACTCCCTACCCAAG 166 (1)
25 ATCTCCTGAAGCCACGTCCC AGGTAGGAGGACCACAACGG 186 (2)
26 TTGCTTTTGGATTGACTCATTGA GCCCTCCCACCTCTACTCA 135 (1)
27 GATCCCAGAGTAAACTCCTTC GTGGGGCCTTGCTTTGCATA 207 (1)
28 ACCCTGCTTCTCCAGTTCC CCGCTTCCCTCCGCTCCTT 280 (2)
29 AGCGACAGTGCGTGGAATAC TGCTCCTCCTGGGACTGAC 182 (1)
30 CACAGCTCCTCCCCTCTCC CTGATGCCTGGGAATCAAAGG 177 (1)
31 TTCCTTTTTAATCCCCATCCTG TCCTGGGGAGGGCAGAGTAA 152 (2)
32 TTTGTCCTTTCTTGTTGGTTCTT AGCAGGCACGGACGGTTAG 182 (2)
33 TACCGGGCATCTTCATGGGA AGAGTGGGGGTGTTAGAGGG 154 (1)
34 GCACCTCCTGTTGCCGACG GGCCGCAGGACATGAGGG 182 (2)
35 CTGCACTCCAGCCTCATGG GCCCCGTGGTGGGAGCCT 132 (2)
36 GGGCTGCATGAACGTGGCT ATGGCTGCTGGCTGTTGAGT 235 (2)
37 GGATGGGCTGCATGAACGTG ATGGCTGCTGGCTGTTGAGTT 239 (1)
38 GAAGGTCTTCTCACAGCACC CTCAGCTTGGGGAATCAGGA 210 (2)
39 CTCTCTGATGCCCTGTCCCT CTCTCCCTCCCATGAACCC 168 (2)
40 GCACCGCCTGCCATCATCA GTCTCTCCCAGTGCCCACG 178 (1)
41 CACCATCTGTGGCTTCCTAC GCGGGAGTCCAGGGAGCA 211 (2)
42 CCCTGCTCCCCTCTTACCC GGCAATGACCAGGACCTTCC 222 (1)
43 GAGGAAAGGGAGCGTGGTC CTTTATAGGGGTCGAGAGTGC 218 (1)
44b TGGGTGCTAAGGGGCTTCTC CGTTGTTGATGTTGGCGTTGG 263 (2)
44b CTCCACCTTCACCCCGAGC TGCAGCACGTGGGCCCTGT 246 (2)
45 TCTCCTTGTCCTCTCATCCC CTGGAGGGCGAGCATGTCAA 267 (1)
45A GCCTTGGTCCAGAGCTAAAG CTGGCACCCTGGGGTAAAG 187 (2)
46 GGAAGGTTGGCAGTTTCTGAT CAGCCTCAGCAGAGGGCAG 205 (1)
47c GGGGTGCAGCTGTCCCTGT CCGCCGACCACATCCAGAG 216 (2)
48 CTGTTTTCCTGCCCTGATGGT GTGGCCTGTCCAAAAGTGTGA 173 (1)
49b CGGCCACTCCTATTAACTCAC AGGAGCCGCAGTGGATGGAT 239 (2)
49b TTGAGGGGGTCGAGTCCAG CCTGCCCATCTGCGAGTCA 221 (2)
50b GTTCCTTTGGTTCTTCATGGCT CCTGCAGTTCACAAAGGGTAA 226 (1)
50b GCCGACAACATCCTCAGCG AACCCATTAGGAACATTGAAACA 241 (1)
a (C), condition; two different conditions were used for PCR, see Experimental Procedures.
b Exons 2, 44, 49, and 50 are long, and each was amplified with two overlapping oligonucleotide pairs.
c Oligonucleotides for exon 47 also amplify an apparent noncoding duplication of the genomic sequences encompassing exons 45–49 found
3 of the CaV1.2 gene. The duplicated exon 47 differs at several nucleotide positions, which should not be mistaken for mutations.
the voltage dependence of activation (Figure 5F). These Ba2 (40 mM) as a charge carrier. Ba2 currents inacti-
vate much slower than Ca2 currents because, in thedata indicate that G406R substantially impairs voltage-
dependent channel inactivation. absence of extracellular Ca2, channel inactivation is
almost entirely dependent on transmembrane voltageTo confirm that the effect of the mutation was primarily
a loss of voltage-dependent inactivation, we recorded (Lee et al., 1985). The time-dependent inactivation was
dramatically reduced by the mutation (Figures 5G andwt and mutant channel activity in Xenopus oocytes using
Cell
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Figure 2. Identical De Novo Cav1.2 Missense Mutation Causes Timothy Syndrome
(A) TS pedigree showing sporadic occurrence of the disease phenotype and de novo G1216A missense mutation. This mutation leads to the
substitution of glycine 406 with arginine (G406R). Circles and squares indicate females and males, respectively. Filled and empty symbols
denote affected and unaffected individuals. Sequence tracings were derived from blood DNA samples unless otherwise indicated.
(B) TS family with two affected children. A small mutant peak (green, arrow) in the mother’s sequence from oral mucosa DNA is apparent.
This peak is not seen in the sequence of her blood DNA, indicating mosaicism. Germline mosaicism explains the presence of two affected
children in this family. The individual with a slash is deceased.
(C) Amino acid sequence alignment showing conservation of glycine 406 from multiple species. Bracket indicates the end of the sixth
transmembrane segment of domain I (DI/S6).
(D) Predicted topology of CaV1.2, showing the location of the mutation.
5H). Next, we determined the voltage dependence of 50% of the current is inhibited) for block of peak current
by nisoldipine was 74 
 7 nM for wt channels (two toinactivation. Whereas wt channels inactivated 90%
after a conditioning pulse to 30 mV, G406R channels six cells per concentration). The IC50 for G406R channels
was 267
 5 nM for peak currents and 136
 11 nM (threeinactivated 20% at the same potential (Figure 5I).
These data demonstrate that the G406R mutation pro- to seven cells per concentration) for current measured at
the end of a 1 s pulse. These data indicate that mutantduces maintained inward Ca2 currents by causing
nearly complete loss of voltage-dependent CaV1.2 chan- channels remain sensitive to dihydropyridines and sug-
gest that these drugs or other calcium channel blockersnel inactivation.
Block of L-type calcium channels by dihydropyridines may be useful to treat TS.
is enhanced by inactivation (Bean, 1984; Sanguinetti
and Kass, 1984). To determine if mutant channels with G406R Prolongs Simulated Action Potentials
A prominent feature of TS is prolongation of the QTdefective inactivation were still affected by these drugs,
we measured nisoldipine block of Ba2 currents in Xeno- interval and lethal arrhythmias. An important function of
CaV1.2 channels is mediating the plateau phase of thepus oocytes. The IC50 (the drug concentration at which
Calcium Channel Mutation in Arrhythmia and Autism
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Figure 3. The Cav1.2 Gene Is Widely Expressed
(A) Human Northern blot analyses show expression of CaV1.2 mRNA containing exon 8A in brain, heart, bladder, prostate, uterus, stomach,
and other tissues.
(B) mRNA dot blot demonstrates expression of CaV1.2 mRNA containing exon 8A in multiple tissues, including many regions of the brain.
cardiac action potential. We predicted that a slowed Ca2 current that prolonged action potential duration by
17% (Figure 6B, blue traces). Simulations also indicatedrate of channel inactivation would prolong the inward
(depolarizing) Ca2 current during the plateau phase and that 35% reduction of the abnormal L-type Ca2 current
could restore normal action potential duration (Figuredelay cardiomyocyte repolarization. We determined
that, in the heart, 23% of CaV1.2 channels contained 6B, red traces). These data indicate that G406R mutation
causes substantial prolongation of cardiac action poten-exon 8A. Thus, in the heterozygous state, only 11.5%
of CaV1.2 channels carry the G406R mutation. To simu- tials, consistent with the QT interval prolongation and
increased risk of arrhythmia in TS.late the effect of the TS mutation, we assumed these
ratios in a dynamic model of a mammalian ventricular
myocyte (Faber and Rudy, 2000). We altered the voltage Discussion
dependence of L-type calcium channel inactivation to
mimic the expected biophysical effects of the mutation We conclude that the G406R mutation of the CaV1.2
L-type calcium channel causes the diverse physiologicalin heterozygous condition (Figure 6A, blue triangles).
The net effect on total CaV1.2 channel inactivation was and developmental defects in TS. Several lines of evi-
dence support this conclusion. First, we identified ansmall. However, this resulted in a maintained inward
Cell
26
Figure 4. The Cav1.2 Gene Is Expressed in Multiple Mouse Tissues
(A) In the brain, the CaV1.2 gene is expressed in cortex (C), hippocampus (H), thalamus (T), hypothalamus (HT), caudate putamen (CP), and
amygdala (A). For all tissues, in situ hybridization experiment with antisense probe is shown in the top panel, and sense probe (control) is
shown beneath.
(B) Magnification shows expression in the granular (GrDG) and polymorph (PoDG) layers of the hippocampal dentate gyrus.
(C) CaV1.2 gene is expressed throughout adult heart.
(D) Higher magnification of heart ventricle.
(E–H) Expression in ductus arteriosus ([E], E12.5), retina (left arrows), and sclera (right arrows) of eye ([F], E16.5), developing digits ([G], E12.5),
and tooth papilla ([H], P0).
identical, de novo missense mutation of the CaV1.2 gene the TS phenotype. Third, the CaV1.2 gene was strongly
expressed in the heart. Gain-of-function mutations ofin 13 of 13 TS individuals. This mutation was not present
in controls, and the affected amino acid G406 was com- this gene would be expected to cause long QT syndrome
and cardiac arrhythmias. Fourth, functional expressionpletely conserved across species. Second, expression
of the CaV1.2 gene in brain, teeth, digits, lungs, ductus of mutant channels demonstrated that G406R had a
dramatic effect on channel inactivation, causing pro-arteriosus, and the immune system was consistent with
Calcium Channel Mutation in Arrhythmia and Autism
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Figure 5. Timothy Syndrome Mutation Reduces Cav1.2 Channel Inactivation
Inactivation is a time-, voltage-, and Ca2-dependent decrease of channel current. (A and B) Wild-type (A) and G406R (B) CaV1.2 channel
currents recorded from CHO cells in response to voltage pulses applied in 10 mV increments from 40 to 60 mV. External solution contained
15 mM CaCl2. Note that inward Ca2 current is markedly prolonged by the mutation. (C) Voltage dependence of Ca2 current inactivation in
CHO cells for wt channels (circles; V1/2  8 mV, k  6.9 mV; n  5) and G406R channels (squares; V1/2  4 mV, k  10.6 mV; n  5). Note
that the overall extent of G406R channel inactivation is reduced and that the Ca2-dependent component of inactivation (ascending limb of
the relationship) is accentuated. These data suggest reduced voltage-dependent inactivation for G406R channels. Reduced inactivation results
in a maintained inward current and delayed repolarization of the action potential.
(D) Time constants of Ca2 current inactivation as a function of voltage (n  5–9).
(E) G406R channels have similar Ca2 current-voltage (I/V) relationship compared to wt.
(F) Voltage dependence of Ca2 current activation is not significantly altered by the mutation (n  9–11).
(G and H) G406R causes nearly complete loss of voltage-dependent channel inactivation. Wild-type (G) and G406R (H) CaV1.2 channel currents
were recorded from Xenopus oocytes in response to voltage pulses applied in 10 mV increments from 70 to 40 mV. External solution
contained 40 mM BaCl2 to eliminate Ca2-dependent inactivation.
(I) Voltage dependence of Ba2 current inactivation in oocytes for wt (V1/2  8 mV, k  8.9 mV; n  7) and G406R channels (V1/2  0 mV, k 
15.9 mV; n  6).
longed inward Ca2 currents. Finally, simulation analysis cal de novo mutation. One reason that G406R always
arose de novo is the early fatality caused by the muta-indicated that the G406R effect on channel function
causes significant action potential prolongation, consis- tion, making its inheritance rare. Two factors may ex-
plain the unusual recurrence of this mutation. First, ourtent with the TS phenotype.
It is remarkable that all TS individuals carry the identi- physiological studies indicate that arginine at this posi-
Cell
28
Figure 6. Computer Modeling Shows Prolonged Action Potentials in G406R Heterozygotes
(A) Simulated voltage dependence of calcium channel current inactivation for wt (circles), G406R (squares), and wt/G406R heterozygotes (blue
triangles). The relative voltage-dependent inactivation gate term fss is plotted as a function of transmembrane voltage. In the heart and brain,
mRNA analysis indicated that 23% of CaV1.2 channels contain exon 8A. As a result, heterozygotes are predicted to express 11.5% mutant
channels, leading to small effect on total CaV1.2 channel inactivation.
(B) Although the net effect on total CaV1.2 channel inactivation is small, cardiac action potentials (upper panel) are prolonged by 17%. L-type
Ca2 currents for wt (black) and heterozygous (blue) channels are shown in the lower panel. Hetrozygous Ca2 currents must be reduced by
35% to simulate normal action potentials (red trace).
tion has a profound gain-of-function effect. Gain-of- veloping digits. It has been shown that destruction of
these cells causes syndactyly (Hurle and Ganan, 1986).function mutations are uncommon and may be domain
It is likely that Ca2-induced cell death (Orrenius et al.,specific. The DI/S6 segment is known to be important
2003) in the apical ectodermal ridge is the mechanismfor voltage-dependent inactivation of calcium channels
of syndactyly in TS. Abnormalities in cell death may also(Herlitze et al., 1997; Shi and Soldatov, 2002; Zhang et
lead to the failure of the developing ductus arteriosusal., 1994). Second, the mutated nucleotide (G1216) is
to properly close (Imamura et al., 2000; Tananari et al.,located in a CpG dinucleotide on the noncoding strand.
2000). Thus, TS demonstrates the importance of Ca2Deamination of a methylated cytosine causes the muta-
signaling in human development. Genetically modifiedtion of CpG to TpG, the most common mechanism for
mice harboring G406R may address mechanistic ques-mutations (Cooper and Youssoufian, 1988; Vitkup et al.,
tions raised by these findings.2003). Transition from C to T would result in the observed
The fact that CaV1.2 is associated with autism is ofG to A change on the coding strand in a subsequent
great interest. The cardinal features of autism are severecycle of DNA replication. Thus, this is a mutational hot-
difficulties in social interaction, communication deficits,spot. Together, these factors explain the unusual recur-
and repetitive or ritualistic behavior. The severity of phe-rence of G406R.
notypes varies considerably in autism spectrum disor-How does a single amino acid substitution of CaV1.2 ders (ASD), which include autism, Asperger’s syndrome,cause the striking phenotypic abnormalities of TS? Ex-
childhood disintegrative disorder, Rett syndrome, and
planations include the great impact of G406R on channel
pervasive developmental disorder not otherwise speci-
function and the wide tissue expression of CaV1.2. In fied (PDD NOS). In the general population, autism spec-
the pancreas, Ca2 mediates insulin secretion by pan- trum disorders affect0.5% of children and cause great
creatic  cells. Episodic dysfunction of CaV1.2 signaling morbidity (Bryson et al., 2003; Volkmar and Pauls, 2003).
likely accounts for the intermittent hypoglycemia that Epidemiologic studies estimate that 200,000–400,000
led to the death of two affected children. In the heart, children are affected in the United States alone (Fom-
maintained depolarizing Ca2 current through mutant bonne, 2003). Despite their importance, very little is
CaV1.2 channels causes lengthening of cardiac action known about the molecular mechanisms of autism spec-
potentials. This, in turn, leads to QT interval prolongation trum disorders (Zoghbi, 2003). Our findings that individu-
and life-threatening arrhythmias. Now that we know the als with TS met the criteria for autism or had severe
molecular basis of TS, prenatal and neonatal diagnosis deficits of language and social development suggest
is feasible. Early diagnosis is important, as cardiac that abnormal Ca2 signaling may contribute to these
arrhythmias and other features of this disorder are disorders. As autism is a uniquely human phenotype,
treatable. future work will focus on the genetic analysis of CaV1.2
By contrast with these physiological defects, many and other calcium channels in nonsyndromic forms of
phenotypic abnormalities of TS, such as syndactyly and autism and autism spectrum disorders. Future studies
congenital heart disease, are developmental. CaV1.2 is will also determine if features of TS are amenable to
calcium channel blocker therapy.highly expressed in apical ectodermal ridge cells of de-
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Experimental Procedures (Promega). Transformed colonies were screened by PCR for the
presence of exons 8 or 8A using the original oligonucleotide pair.
To identify colonies carrying only exon 8A, the same colony collec-Subject Ascertainment and Phenotypic Analysis
Informed consent or assent was obtained from all individuals or their tion was then tested using a forward oligonucleotide specific to
exon 8A (8AF5-CTGGGTCAATGATGCCGTAG) and the 9R reverseguardians according to standards established by local institutional
review boards. Phenotypic analyses included history, physical ex- oligonucleotide. DNA from 30 of 157 clones was sequenced to con-
firm the results. To control for the cloning efficiency of the fragmentsamination, electrocardiography, and echocardiography. Five chil-
dren were evaluated for behavioral phenotypes and cognitive devel- carrying each exon, we cloned PCR fragments amplified from a
template mixture of cDNA containing exon 8 and cDNA containingopment. These tests included the Diagnostic Criteria for Autistic
Disorder, DSM-IV, Autism Screening Questionnaire, Autism Diag- 8A in a 1:1 ratio and screened colonies as detailed above. No differ-
ence in cloning efficiency was observed.nostic Interview—Revised, the Child Behavior Checklist, Vineland
Adaptive Behavior Scales, and the Autism Diagnostic Observation Nonradioactive in situ hybridization was performed as described
(Berger and Hediger, 2001), using a digoxigenin (DIG)-labeled 800Schedule (Berument et al., 1999; Lord et al., 1994, 2000; Task Force
on DSM-IV, 2000). Cognitive and language tests included Differential nucleotide cRNA probe from the C-terminal region of the mouse
CaV1.2 gene. The probe was derived from a PCR fragment amplifiedAbility Scales, Clinical Evaluation of Language Fundamentals—III,
Goldman-Fristoe Test of Articulation, and NEPSY (Korkman et al., from mouse heart Marathon-Ready cDNA (BD Biosciences Clon-
tech) using MF5-AGGCTGGCTTGCGCACCTT and MR5-GAGA1998).
GATGTCTCCCCCTTGA oligonucleotides. Frozen sections (10 m)
were cut in a cryostat and captured onto Superfrost Plus microscopeStatistical Analysis
slides (Fisher). Sections were then fixed, acetylated, and hybridizedFisher’s exact test and data from the study with highest prevalence
to the probe (approximate concentration 100 ng/ml) over three nights atof autism and autism spectrum disorders (60 of 8,896 individuals)
70C. Hybridized probe was visualized using alkaline phosphatase-were used to determine the p value for the association of these
conjugated anti-DIG Fab fragments (Roche) and 5-bromo-4-chloro-disorders and TS (Bertrand et al., 2001). This comparison gave the
3-indolyl-phosphate/nitro-blue tetrazolium (BCIP/NBT) substratemost conservative estimate of the p value. Fisher’s exact test was
(Kierkegard and Perry Laboratories). Sections were rinsed severalalso used to assess the p value for the association of G406R with
times in 100 mM Tris, 150 mM NaCl, and 20 mM EDTA (pH 9.5) andthe TS phenotype.
coverslipped with glycerol gelatin (Sigma). Control sections were
incubated with identical concentration of the sense probe transcript.Genotypic and Sequence Analyses
Digital images for antisense and sense probes for each section wereGenomic DNA from peripheral blood lymphocytes or cell lines de-
captured using identical microscope settings.rived from Epstein-Barr virus-transformed lymphocytes was pre-
pared using Puregene DNA isolation kit (Gentra Systems). Genomic
DNA Constructs for Functional ExpressionDNA from buccal swabs and sperm was prepared using QIAamp
Full-length human wt CaV1.2 cDNAs (accession number Z34815),DNA Mini Kit (Qiagen). Oligonucleotides to all known exons of the
cloned in a Xenopus (pBluescript) and mammalian (pcDNA3) expres-CaV1.2 gene were designed to genomic sequences found in the
sion vector systems, were a generous gift from Dr. N. Soldatov. TheCelera database using Oligo6.6 (Molecular Biology Insights, Table
G406R mutation was introduced by site-directed mutagenesis using2). PCR amplification of DNA samples and mutational analyses were
QuikChange (Stratagene) into the Xenopus expression clone. Sub-carried out as previously described (Splawski et al., 1997b). Two
sequently, an AfeI/SgrAI fragment containing the introduced muta-different conditions were used for PCR: (1) 94C for 2 min, 35 cycles
tion was cloned into the AfeI and SgrAI sites of the wt pcDNA3of 10 s at 94C, 20 s at 58C, and 20 s at 72C, followed by 5 min
clone to obtain the mammalian G406R expression construct.extension at 72C; and (2) same as (1), but annealing was done at
CaV2b is the  subunit splice variant associated with CaV1.2 in54C, and the PCR reaction had a final concentration of 10% glycerol
the human heart (Colecraft et al., 2002). We obtained a cDNA cloneand 4% formamide (Table 2).
containing the 5 end sequence of CaV2b from RZPD (cloneOligonucleotides OriF5-TACACTAATCATCATAGGGTCAT and
DKFZp313F1242, RZPD, Germany) and purchased the splice variantOri2R5-TAGCGATTCCCAGTTTAGGTAC were used to amplify a
CaV2a (the 3 sequences of CaV2a and CaV2b are identical) fromfragment of 1122 nucleotides containing part of exon 8A and adja-
Genecopoeia (clone GC-T4617, Genecopoeia). EcoRI/PshAI frag-cent intron 8A sequences. PCR products were obtained with Pfu
ment from DKFZp313F1242 and PshAI/NotI fragment from GC-Ultra HF DNA polymerase (Stratagene), purified, and sequenced.
T4617 were cloned into the EcoRI and NotI sites of pcDNA3.1 (In-An intronic polymorphism (C to G) was identified 344 nucleotides
vitrogen) to obtain the full-length cDNA clone for human CaV2bdownstream from exon 8A. PCR fragments were then cloned using
(accession number AAG01473). The rabbit CaV2b clone (accessionthe PCR-Script Amp Cloning Kit (Stratagene) to separate the prod-
number CAA45575, amino acid sequence 96% identical to humanucts derived from individual chromosomes. DNA from several clones
CaV2b) for expression in Xenopus oocytes was a kind gift from Dr.for each individual was sequenced to determine the parent chromo-
N. Dascal.some on which the mutation arose.
CaV21 is the 2 subunit associated with CaV1.2 in the heart
(Arikkath and Campbell, 2003). Full-length clone for the humanmRNA Expression and cDNA Analyses
CaV21 subunit (accession number NP_000713) was obtained byBlot analyses were performed using human 12-lane multiple-tissue
ligation of a NotI/Bpu10I fragment from IMAGE clone 2006073 andNorthern blots I and III (BD Biosciences Clontech). mRNA dot blot
a Bpu10I/XbaI fragment from a PCR product, amplified from humananalysis was performed using the Multiple Tissue Expression Human
heart Marathon-Ready cDNA (BD Biosciences Clontech) using oli-Array 3 (BD Biosciences Clontech). A 115 base pair PCR fragment,
gonucleotides A2D1F5-TGAATGTAGCTTCATTTAACAGCA-3 andamplified using HF5-TGGGTCAATGATGCCGTAGG and HR5-GAA
A2D1XbaR5-GCTCTAGATTTGGCAGGGTCTGGAGTTTAAC-3 (XbaIAACTCTCCGCTAAGCACA oligonucleotides, was used as a probe
site underlined), into the NotI and XbaI sites of pcDNA3.1 (In-for exon 8A containing mRNAs. The fragment was labeled with the
vitrogen). The rabbit CaV21 clone (accession number AAA81562,Prime-It II labeling kit (Stratagene) using the reverse (HR) oligonucle-
amino acid sequence 96% identical to human CaV21) for expres-otide instead of the provided random 9-mers. Hybridization and
sion in Xenopus oocytes was a kind gift from Dr. N. Dascal.washing conditions followed manufacturer’s suggestions. The blots
The full-length clones for all eight expression constructs de-were exposed to film for 3 days.
scribed above were sequenced in forward and reverse direction andHuman heart marathon-ready cDNA (BD Biosciences Clontech)
compared to genomic DNA to ensure that no unintended mutationsand human heart and brain race-ready cDNAs (Ambion) were ana-
were present or introduced.lyzed to estimate the ratio of CaV1.2 transcripts containing exon 8A
to transcripts containing exon 8. Briefly, PCR products amplified
using the 7F and 9R oligonucleotides (forward from exon 7, 7F5- Transfection and Solutions for CHO Cells
CHO cells were cultured in Ham’s F-12 Media and transiently trans-TCACGGTGTTCCAGTGCATC and reverse from exon 9, 9R5-CAG
GTAGCCTTTGAGATCCTC) were ligated into pGEM-T Easy Vector fected using Lipofectamine 2000 (GIBCO). Cells were transfected
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for 18 hr in 35 mm dishes containing 18 l Lipofectamine, 242 l W. Reynolds Foundation (M.T.K. and I.S.), Fondazione Telethon, and
Fondazione Cariplo (S.G.P.) is gratefully acknowledged.Optimem (GIBCO), 0.86g enhanced green fluorescent protein (Mo-
lecular Probes), 4 g of either wt or mutant human CaV1.2, and
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